Clinical Trials Browser

Phase 3 × Radiodermatitis × Clear all

NCT02839473 2025-09-19

HYDROSORB

Phase 3 Completed

Breast Neoplasms, Radiodermatitis

NCT07149506 2025-09-08

OCTOPUS-RD

Phase 3 Enrolling by invitation

Fibrosis, Radiodermatitis

NCT07066280 2025-07-15

Modulating the Skin Microbiome to Prevent Radiation Dermatitis in Breast Cancer

Phase 3 Recruiting

Breast Neoplasms, Radiodermatitis

NCT06915857 2025-05-21

Topical Betamethasone Versus Moisturizer in Preventing Radiation Dermatitis in Large-Breasted Patients Treated in the Prone Position

Phase 3 Recruiting

Breast Neoplasms, Radiodermatitis

NCT03753776 2025-04-09

HOMEORAD

Phase 3 Completed

Breast Neoplasms, Radiodermatitis

NCT02369835 2024-01-30

Modified Dakin's Solution in Reducing Radiation-Induced Dermatitis in Patients With Head and Neck Cancer Undergoing Radiation Therapy

Phase 3 Completed

132 enrolled 9 charts

Radiodermatitis

NCT01520701 2023-07-27

IPAC

Phase 3 Completed

Head and Neck Neoplasms, Radiodermatitis

NCT04300829 2021-02-04

CICA-RT

Phase 3 Unknown

Radiation Injuries, Radiodermatitis

NCT02247830 2020-10-08

PRBHNC

Phase 3 Completed

BreastHead & Neck

Breast Neoplasms, Head and Neck Neoplasms, Radiodermatitis

NCT04239560 2020-01-28

boron_gel

Phase 3 Completed

Breast Neoplasms, Radiodermatitis

NCT00156806 2017-01-24

Investigating the Therapeutic Effectiveness of Aloe Barbadensis in Reducing Cutaneous Side-Effects of Radiation Treatment for Breast Cancer.

Phase 3 Completed

Breast Neoplasms, Radiodermatitis

NCT00481884 2016-05-02

Comparing RadiaPlexRx Hydrogel and Standard-of-Care for Radiation Dermatitis in Breast Cancer Patients

Phase 3 Completed

Breast Neoplasms, Radiodermatitis

NCT02251392 2015-12-02

ChamomillaTH

Phase 3 Unknown

BreastHead & Neck

Breast Neoplasms, Head and Neck Neoplasms, Radiodermatitis